Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Government of Canada was posted on June 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Supply of Ultra-High-Performance Liquid Chromatography System (UHPLC-DAD-FLD)

Closed
International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334516
New
SLED
Chromatography Quadrupole Time-of-Flight (LC-QTOF) Instruments
Solicitation # SRC0000042863
The Ohio Attorney General’s Office (AGO) Bureau of Criminal Investigation (BCI) Laboratory is soliciting bids under solicitation SRC0000042863 for the procurement of three Liquid Chromatography Quadrupole Time-of-Flight (LC-QTOF) instrument systems. These systems will be deployed across three laboratory locations in Bowling Green, Richfield, and London to enhance the analysis and characterization of controlled substances. The scope of work requires the vendor to furnish, deliver, install, configure, and test the equipment, which includes mass spectrometers, liquid chromatography systems, nitrogen generators, and associated software licenses for data acquisition and informatics integration. Additionally, the vendor must provide three days of on-site training at each location and a five-year enhanced extended manufacturer-backed warranty. The contract will be awarded based on the vendor's ability to meet technical specifications and provide comprehensive pricing, though the lowest price quote is not the sole determining factor. Bidders must submit their responses online via the Ohio Buys portal by the November 18, 2026, deadline. All equipment must be new or manufacturer-certified pre-owned. Key compliance requirements include adherence to U.S. trade control laws, certification against unresolved findings for recovery under the Ohio Revised Code, and compliance with equal employment opportunity laws. Delivery is specified as F.O.B. Destination, and the contract is subject to the availability of lawful appropriations through the biennium ending June 30, 2027.
Attorney General, Ago461700 Bci Laboratory Bciihq

POSTED

about 8 hours ago

DEADLINE

in 15 days
NAICS: 334516
New
SLED
ML2 ALS Light Source
Solicitation # SRC0000042834
Solicitation SRC0000042834 is issued by the Ohio Attorney General's Office for the procurement of one Crime-Lite ML2 illuminated bench magnifier system. This specialized equipment is used for detecting evidence such as blood spatter, body fluids, fibers, and drug residues. The system must include illumination modules with specific peak wavelengths for UV2 (365 nm), Violet (405 nm), and Blue (445 nm), and must be classified according to European Safety Standard EN62471:2008. Each module and the bench magnifier must be delivered with an information sheet and a wavelength output certificate. The contract will be awarded to the supplier offering the lowest responsive and responsible quote. Invoices must be emailed to [email hidden] and include the purchase order number, with payments due on the 30th calendar day after receipt of a proper invoice. Delivery is to be coordinated through Kristina Crowley at the Richfield Regional Office. This agreement is governed by the laws of the State of Ohio, with the Court of Claims in Franklin County serving as the exclusive venue for disputes. Vendors must certify they are not subject to unresolved findings for recovery under ORC 9.24 and are not boycotting jurisdictions with which Ohio maintains open trade. Performance is contingent upon the availability of funds appropriated by the Ohio General Assembly.
Attorney General, Ago461700 Bci Laboratory Richro

POSTED

about 12 hours ago

DEADLINE

in 15 days

AI Contract Overview

Show more

The contract involves the supply, delivery, and basic installation support of an Ultra-High-Performance Liquid Chromatography system equipped with Diode Array Detection and Fluorescence Detection (UHPLC-DAD-FLD) for analytical testing purposes at the Health Canada Products Laboratory. This procurement is managed by the Department of Health under the Government of Canada. The acquisition aims to enhance the laboratory's analytical capabilities, ensuring more precise and efficient testing. The solicitation was posted on June 12, 2026, with a response deadline set for July 2, 2026. It is categorized as a subcontract under NAICS code 334516, which pertains to analytical laboratory instrument manufacturing. The place of performance is within Canada, but specific location details or contact points are not provided. The contract supports the government’s efforts to maintain high standards in health product testing through updated and advanced instrumentation.

General Info

Supply, delivery, and installation of UHPLC-DAD-FLD system for Health Canada analytical testing.

Documents

This scope was carved out of 1000272585.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Ultra high-performance liquid chromatography system with diode array and fluorescence detection

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyGovernment of Canada → Department of Health
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply, delivery, and basic installation support for a new UHPLC-DAD-FLD system for analytical testing at the Health Canada Products Laboratory.

More opportunities from Government of Canada → Department of Health

Same awarding agency

NAICS: 541380
New
International
Illumina and PacBio Sequencing of Human and Mouse DNA and RNA
Solicitation # 1000273702
Health Canada's Mechanistic Studies Division is seeking high-throughput genome sequencing services to support four research projects focused on identifying environmental mutagens and evaluating occupational hazards. The contract requires the use of Illumina and Pacific Biosciences (PacBio) Revio platforms to sequence pre-prepared DNA libraries, genomic DNA, and RNA from human and mouse samples. Key technical deliverables include whole-genome sequencing, whole-exome sequencing with a minimum mean depth of 100x, and RNA sequencing with at least 20 million reads per sample. The resulting data will be used to characterize spontaneous and induced mutations and gene expression changes to improve toxicological testing and human health risk assessments. The contract follows a lowest evaluated price selection process based on mandatory technical criteria, including the provision of a no-cost quality control portal, cloud-based software for downloading bam and fastq files for at least 90 days, and evidence of validated sequencing workflows. The initial term runs from the date of award until March 31, 2027, with the possibility of four optional one-year extensions extending the performance period to March 20, 2031. All work is to be performed at the contractor's facilities, and the contractor must ensure that all sequencing and quality control are conducted by experienced personnel. Invoices are to be submitted electronically and will be paid within 30 days of receipt.
Testing Laboratories and Services

POSTED

about 23 hours ago

DEADLINE

in 30 days
View Details
NAICS: 541380
New
International
Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.
Solicitation # 1000273405-1A
Health Canada is seeking proposals for in vitro pharmacological testing of novel psychoactive substances to support regulatory decision-making under the Controlled Drugs and Substances Act. The procurement is divided into two separate streams: Stream 2 focuses on evaluating the affinity, potency, and efficacy of thirty novel synthetic cannabinoids at CB1 and CB2 receptors, while Stream 3 involves testing fifteen stimulant compounds and three controls to assess dopamine uptake and release at DAT and VMAT2. The objective is to generate critical scientific data on these emerging drugs to better understand their risks and inform risk assessments for the Canadian population. The contracts are firm-price awards with maximum financial bids of 70,000 CAD for Stream 2 and 80,000 CAD for Stream 3. Evaluation is based on a weighted score of 70 percent technical merit and 30 percent price. Technical requirements include demonstrated experience in pharmacodynamics, peer-reviewed publications, and specific expertise with the relevant receptors or transporters. Awarded contractors must operate from their own laboratories, maintain all necessary controlled substance licenses, and provide a comprehensive safety plan for handling hazardous compounds. The performance period extends to March 31, 2028, with key deliverables including assay validation and final scientific reports due between 15 and 17.5 months after the contract award.
Testing Laboratories and Services

POSTED

2 days ago

DEADLINE

in 6 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS